NUSHORES BIOSCIENCES LLC
Little Rock, AR · Founded 2013 · CIK 0001704519 · Medtech · Private
NuCress™ bone scaffold - a resorbable, shape-modifiable synthetic bone graft material for dental implant reconstruction
nushores.com →- Grants
- $5.0M
- 6 awards
- Sector median: 1
- Raised
- $350K
- 2 Form D · Aug 2020
- 74 months since last filing
- Contracts
- $4.3M
- 2 awards · Defense
- #134 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $100,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Feasibility study of a nanostructural system for bone regeneration in preparation for dental implants | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Feasibility study of a nanostructural system for bone regeneration in preparation for dental implants | $676,207 | |
| Federal grant | Department of Health and Human Services · Phase II · Feasibility study of a nanostructural system for bone regeneration in preparation for dental implants | $822,455 | |
| Private capital raised | Form D · SEC | $250,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Feasibility study of a nanostructural system for bone regeneration in preparation for dental implants | $71,837 | |
| Federal grant | Department of Health and Human Services · Phase II · Feasibility study of a nanostructural system for bone regeneration in preparation for dental implants | $177,317 | |
| Federal grant | Department of Health and Human Services · Phase II · Commercialization Readiness for Bone Filler Scaffold Device to Aid in Dental Applications and Reconstruction | $3,006,953 | |
| Federal contract | Department of Defense · Dha SBIR 2ND Ph II H2S-0068 Medical Research And Development Contract Titled Product Development And Commercialization Readiness For A Class Of Ether-based Bioresorbable Polyurethanes For Biomedical Applications. | $1,300,000 | |
| Federal contract | Department of Defense · Nushores Dha SBIR D Ph II H2D-0202 Catalytically Active Device That Removes Ethylene Oxide (eto) Used In Sterilization Processes | $3,000,000 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 131 | ROBIN MEDICAL INC | $4.5M | — |
| 132 | ADAPTIVE BIOTECHNOLOGIES CORPORATION | $4.4M | $507M |
| 133 | L2 DIAGNOSTICS LLC | $4.4M | — |
| 134 | NUSHORES BIOSCIENCES LLC | $4.3M | $350K |
| 135 | TRACE BIOSCIENCES INC | $4.2M | — |
| 136 | ShockWave Medical, Inc. | $4.2M | $110M |
| 137 | NOWDiagnostics, Inc. | $4.1M | $43M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Sharon BallardDirector · Executive Officer
- Alex BirisDirector · Executive Officer
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.